Report additional clinical and immunogenicity data for the GEN-009 trial
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 11 Feb 2021
- Due
- 30 Jun 2021
- Delivered
- June 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Genocea expects to provide additional clinical and immunogenicity data from these patients in Q2.”
What we found
Evidence strength A What the grades mean
The company reported long-term immunogenicity and clinical response data for the GEN-009 trial at the American Society of Clinical Oncology Annual Meeting in June 2021, meeting the Q2 deadline.
-
A Genocea Biosciences, Inc. 10-Q filed 2021-07-29
“Genocea reported long-term immunogenicity and clinical response data from its GEN-009 neoantigen Phase 1 clinical trial in June 2021” ✓ confirmed on the page
-
A Genocea Biosciences, Inc. 10-Q filed 2021-07-29
“We have observed the following from our data, most recently presented at the American Society of Clinical Oncology Annual Meeting in June 2021” ✓ confirmed on the page
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- GEN-009 clinical and immunogenicity data
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Genocea Biosciences, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C457612-023645 · Corrections policy